Sector Perspective Therapeutics, Inc.

Aandelen

CATX

US46489V3024

Biotechnologie & Medisch Onderzoek

Beurs gesloten - NYSE 22:00:00 28-07-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
2,870 USD +1,77% Intraday-grafiek van Perspective Therapeutics, Inc. -3,69% +4,36%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
+1,77%-3,69%-19,15%-27,34%+4,36%-30,34%-51,36%-59,35%-63,47% 322 mln.
+0,14%-0,85%+4,79%+14,65%+4,17%-1,20%+11,73%-17,93%+206,12% 47,74 mld.
-2,24%+0,31%-4,55%+26,95%+130,83%+393,45%+615,13%+521,15% - 39,98 mld.
+1,40%+3,69%+13,96%+10,83%+8,77%+12,21%+46,79%+5,68%+1.106,06% 36,23 mld.
+13,94%+20,49%+25,69%+52,81%+7,78%+22,85%+7,42%-0,99%+211,78% 35,59 mld.
-0,73%+2,78%+6,93%-8,69%+2,91%+4,65%+41,16%-18,11%+147,26% 27,91 mld.
+0,40%-0,30%-3,51%+14,57% - - - - - 16,71 mld.
-3,12%+7,39%+6,78%+39,38%+1,66%+26,03%+124,08%+226,85% - 16,45 mld.
+2,39%-3,63%-0,64%+11,34%+9,81%-0,35%+10,34%-31,85%+102,06% 13,21 mld.
+6,79%+8,17%+4,19%+75,86%-1,09%-4,97%-28,52%-21,73%+129,05% 12,93 mld.
+0,63%+0,61%+1,65%+34,69%+22,55%+23,09%-13,99%-39,53%+160,23% 11,16 mld.
-3,89%-7,87%+28,76%+12,57%-9,63%+90,88%+503,77%+251,53%+2.484,32% 11,1 mld.
+7,19%+9,59%+6,59%+44,15%+20,53%+34,33%+14,22%-39,84%+174,78% 10,8 mld.
-0,08%-0,02%+1,18%+57,16%+77,76%+238,30%+546,60% - - 10,08 mld.
-2,71%+1,18%+43,31%+28,61%+32,68%+25,73%+45,86%-54,49% - 9,54 mld.
-1,18%+3,58%-31,47%-22,96%-30,10%+34,32%+38,98%+46,57%+91,75% 9,25 mld.
-3,53%-6,36%-2,89%+26,61%+36,43%+140,18%+386,08%+78,21% - 9,05 mld.
-6,33%-6,94%-15,62%-8,11%+0,36%+431,55%+1.912,31%+24,74% - 8,8 mld.
-4,23%-4,45%-3,86%+47,92%+80,49%+93,12%+75,59%+95,96%+4,92% 8,79 mld.
+0,94%-1,06%+12,51%+35,20%+56,68%+143,23%+616,82%+191,21% - 8,72 mld.
Gemiddelde +0,46%+1,18%+3,73%+23,31%+24,05%+88,27%+258,05%+64,34%+396,24% 17,22 mld.
Gewogen gemiddelde per kap. +1,38%+2,14%+6,41%+24,27%+27,37%+88,95%+208,52%+87,92%+429,72%
Biotechnologie & Medisch Onderzoek - Andere
  1. Beurs
  2. Aandelen
  3. Koers CATX
  4. Sector Perspective Therapeutics, Inc.